Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis
Clinical trial NCT02687724 · UNKNOWN
Trial details
- NCT number
- NCT02687724
- Sponsor
- University College Dublin
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2020-02-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.